Alvarez-Dominguez C, Carrasco-Marin E, Leyva-Cobian F
Servicio de Immunología, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Infect Immun. 1993 Sep;61(9):3664-72. doi: 10.1128/iai.61.9.3664-3672.1993.
Listeria monocytogenes is a facultative intracellular pathogen of a great variety of cells. Among them, macrophages constitute the major effector cells of listerial immunity during the course of an infection. Although the molecular bases of L. monocytogenes attachment and entry to phagocytes are not completely understood, it has been demonstrated that C3b significantly increases L. monocytogenes uptake by macrophages via complement receptor type 3. The first component of complement, C1q, is present in organic fluids at a relatively high concentration, and C1q receptor sites in macrophages are also abundant. In the present report, results of studies on the role of C1q in the internalization and infectivity of L. monocytogenes by macrophages are presented. L. monocytogenes uptake is enhanced by prior treatment of bacteria with normal sera. Heated serum or C1q-deficient serum abrogates this enhancement. Purified C1q specifically restored uptake. This effect was blocked by the addition of F(ab')2 anti-C1q antibody but not by an irrelevant matched antibody. Direct binding of C1q to L. monocytogenes was specific, saturable, and dose dependent with both fluorescent and radiolabeled C1q. N-Acetyl-D-alanyl-L-isoglutamine, diaminopimelic acid, and L-rhamnose caused a significant dose-dependent inhibition of C1q binding to bacteria, suggesting that these molecules, at least, are involved in the attachment of C1q to L. monocytogenes cell wall. When C1q binding structures on macrophage-like cells were blocked with saturating concentrations of C1q, the uptake of C1q-opsonized bacteria was less than in untreated cells. These experiments demonstrate that, in addition to other reported mechanisms, L. monocytogenes binds C1q, which mediates enhanced uptake by macrophages through C1q binding structures.
单核细胞增生李斯特菌是多种细胞的兼性细胞内病原体。其中,巨噬细胞是感染过程中李斯特菌免疫的主要效应细胞。尽管单核细胞增生李斯特菌附着并进入吞噬细胞的分子基础尚未完全明确,但已证实C3b通过3型补体受体显著增加巨噬细胞对单核细胞增生李斯特菌的摄取。补体的第一成分C1q以相对较高的浓度存在于体液中,巨噬细胞中的C1q受体位点也很丰富。在本报告中,展示了关于C1q在巨噬细胞内化和感染单核细胞增生李斯特菌中的作用的研究结果。用正常血清预先处理细菌可增强单核细胞增生李斯特菌的摄取。加热的血清或C1q缺陷血清可消除这种增强作用。纯化的C1q可特异性恢复摄取。添加F(ab')2抗C1q抗体可阻断这种效应,但无关的匹配抗体则不能。C1q与单核细胞增生李斯特菌的直接结合具有特异性、可饱和性,且与荧光和放射性标记的C1q均呈剂量依赖性。N-乙酰-D-丙氨酰-L-异谷氨酰胺、二氨基庚二酸和L-鼠李糖可显著剂量依赖性地抑制C1q与细菌的结合,表明这些分子至少参与了C1q与单核细胞增生李斯特菌细胞壁的附着。当用饱和浓度的C1q阻断巨噬细胞样细胞上的C1q结合结构时,C1q调理的细菌的摄取少于未处理的细胞。这些实验表明,除了其他已报道的机制外,单核细胞增生李斯特菌还结合C1q,C1q通过C1q结合结构介导巨噬细胞增强摄取。